Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
about
Facioscapulohumeral dystrophy: the path to consensus on pathophysiologyMulti-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapyFacioscapulohumeral Dystrophy.Altered expression of cyclin A 1 in muscle of patients with facioscapulohumeral muscle dystrophy (FSHD-1)Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical TrialsInfluence of immune responses in gene/stem cell therapies for muscular dystrophies.Upper girdle imaging in facioscapulohumeral muscular dystrophy.Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cellsMultiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular DystrophyMuscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophyMuscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltrationAntisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials.Do's and don'ts in the preparation of muscle cryosections for histological analysis.PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.Magnetic resonance imaging in facioscapulohumeral muscular dystrophy.Adding quantitative muscle MRI to the FSHD clinical trial toolbox.A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy.Facioscapulohumeral Muscular Dystrophy.Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle.Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.MRI-Guided Biopsy as a Tool for Diagnosis and Research of Muscle Disorders
P2860
Q21195884-18A28F6E-EFD2-465B-8D85-290D54D019BCQ27308877-80FA0A78-FA8C-4B8C-9708-2F7BD3DDBDECQ30250223-3332079D-D1AE-43E1-921C-13E6A4076C60Q31137613-90E995D5-B5E9-41F1-9C74-8BDBDE9C8624Q31142754-F528A387-657B-4ECF-AE26-C897AD474344Q33736192-F0BF4464-2DDB-46EC-A5ED-0A5EF1B7DB08Q33763548-542B225E-74DD-442E-87D0-D4B9D0798980Q34685919-1F2D0F9E-C7AA-4928-B127-A7B13BBFA1DFQ34746238-3A6AA50B-324E-49D7-A224-8A8D8D6DD96FQ35094699-730A4B43-50D6-4A39-94EB-6F7D69B62675Q35693421-23C84C2B-D7B2-4D38-8ACD-793B953A9D69Q35858791-17F0AB1D-3720-43A1-A2DB-8B70D06B037AQ35988817-7F40C365-2184-4A0B-8C74-4AEFF1D337EDQ36397532-B2A5FD7A-84B6-4AC6-9FE6-05199CA5FE46Q37478796-FB70BC73-0290-4318-9F1A-538FC18B2C71Q37724109-6AFD1CD3-AF53-4C94-8511-CFBC7CBDA040Q39905506-CA314D54-397A-4B9B-BFE5-3D357819119BQ42700190-E66EF53E-3EC8-4BEC-BFCC-F6E276A388DBQ47146410-CADFF5B5-AA1D-4DC6-99D9-D4ED49860EADQ48131113-6B6F00B7-E8DC-4273-A341-D0CA2CFDA8C3Q48214729-ED8388AF-AAC5-47E5-9AE5-95467455629CQ48254104-D8814F70-11F5-4E59-B1A9-4F0BE31DA53DQ50067106-D49463E8-6D58-42A3-A222-EB7C67C3F6B5Q50133251-B107464D-FF59-4C21-9C00-A12BD15A2078Q52506936-5A1E1B27-8CA9-4EAA-9656-B53EA0C9FECFQ52714812-06D0E04D-B641-4C3B-AF12-522CA80E755AQ53550688-46189910-DB5E-4430-8E91-0C814D718EE5Q58803312-F5AAAF7E-00F5-42EA-A42D-9FA52F16469A
P2860
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Different molecular signatures ...... al muscular dystrophy muscles.
@ast
Different molecular signatures ...... al muscular dystrophy muscles.
@en
Different molecular signatures ...... al muscular dystrophy muscles.
@nl
type
label
Different molecular signatures ...... al muscular dystrophy muscles.
@ast
Different molecular signatures ...... al muscular dystrophy muscles.
@en
Different molecular signatures ...... al muscular dystrophy muscles.
@nl
prefLabel
Different molecular signatures ...... al muscular dystrophy muscles.
@ast
Different molecular signatures ...... al muscular dystrophy muscles.
@en
Different molecular signatures ...... al muscular dystrophy muscles.
@nl
P2093
P2860
P1433
P1476
Different molecular signatures ...... al muscular dystrophy muscles.
@en
P2093
Elisabetta Iannaccone
Enzo Ricci
Francesco Laschena
Giorgio Tasca
Mario Pescatori
Massimiliano Mirabella
Mauro Monforte
Pierfrancesco Ottaviani
Roberto Frusciante
Tiziana Cubeddu
P2860
P304
P356
10.1371/JOURNAL.PONE.0038779
P407
P577
2012-06-13T00:00:00Z